Effects of finasteride on serum testosterone and body mass index in men with benign prostatic hyperplasia
- 1 November 2003
- Vol. 62 (5) , 894-899
- https://doi.org/10.1016/s0090-4295(03)00661-7
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- The Long-Term Effect Of Specific Type II 5α-Reductase Inhibition With Finasteride on Bone Mineral Density in Men: Results of a 4-Year Placebo Controlled TrialJournal of Urology, 2002
- Obesity and Disease Management: Effects of Weight Loss on Comorbid ConditionsObesity Research, 2001
- Prostate Volume and Serum Prostate–Specific Antigen as Predictors of Acute Urinary RetentionEuropean Urology, 2000
- Finasteride in the treatment of men with androgenetic alopeciaJournal of the American Academy of Dermatology, 1998
- Long-Term Effects of Finasteride in Patients with Benign Prostatic Hyperplasia: A Double-Blind, Placebo-Controlled, Multicenter StudyUrology, 1998
- The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment among Men with Benign Prostatic HyperplasiaNew England Journal of Medicine, 1998
- Finasteride significantly reduces acute urinary retention and need for surgery in patients with symptomatic benign prostatic hyperplasiaUrology, 1997
- Can finasteride reverse the progress of benign prostatic hyperplasia? a two-year placebo-controlled studyUrology, 1995
- The Effect of Finasteride in Men with Benign Prostatic HyperplasiaNew England Journal of Medicine, 1992
- Effects of Finasteride (MK-906), a 5α-Reductase Inhibitor, on Circulating Androgens in Male Volunteers*Journal of Clinical Endocrinology & Metabolism, 1990